» Articles » PMID: 14675751

TIMP-3 Inhibits Aggrecanase-mediated Glycosaminoglycan Release from Cartilage Explants Stimulated by Catabolic Factors

Overview
Journal FEBS Lett
Specialty Biochemistry
Date 2003 Dec 17
PMID 14675751
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Aggrecanases are considered to play a key role in the destruction of articular cartilage during the progression of arthritis. Here we report that the N-terminal inhibitory domain of tissue inhibitor of metalloproteinases 3 (N-TIMP-3), but not TIMP-1 or TIMP-2, inhibits glycosaminoglycan release from bovine nasal and porcine articular cartilage explants stimulated with interleukin-1alpha or retinoic acid in a dose-dependent manner. This inhibition is due to the blocking of aggrecanase activity induced by the catabolic factors. Little apoptosis of primary porcine chondrocytes is observed at an effective concentration of N-TIMP-3. These results suggest that TIMP-3 may be a candidate agent for use against cartilage degradation.

Citing Articles

Synergetic enrichment of aggrecan in nucleus pulposus cells by scAAV6-shRNA-mediated knockdown of aggrecanase-1 and aggrecanase-2.

Mern D, Thome C Exp Biol Med (Maywood). 2023; 248(13):1134-1144.

PMID: 37354087 PMC: 10583755. DOI: 10.1177/15353702231171905.


Targeting Dysregulation of Metalloproteinase Activity in Osteoarthritis.

Yamamoto K, Wilkinson D, Bou-Gharios G Calcif Tissue Int. 2020; 109(3):277-290.

PMID: 32772139 PMC: 8403128. DOI: 10.1007/s00223-020-00739-7.


Biology of Tissue Inhibitor of Metalloproteinase 3 (TIMP3), and Its Therapeutic Implications in Cardiovascular Pathology.

Fan D, Kassiri Z Front Physiol. 2020; 11:661.

PMID: 32612540 PMC: 7308558. DOI: 10.3389/fphys.2020.00661.


Aggrecanase-selective tissue inhibitor of metalloproteinase-3 (TIMP3) protects articular cartilage in a surgical mouse model of osteoarthritis.

Nakamura H, Vo P, Kanakis I, Liu K, Bou-Gharios G Sci Rep. 2020; 10(1):9288.

PMID: 32518385 PMC: 7283274. DOI: 10.1038/s41598-020-66233-0.


Aggrecan Turnover in Women with Rheumatoid Arthritis Treated with TNF-α Inhibitors.

Szeremeta A, Jura-Poltorak A, Zon-Giebel A, Kopec-Medrek M, Kucharz E, Olczyk K J Clin Med. 2020; 9(5).

PMID: 32392807 PMC: 7290997. DOI: 10.3390/jcm9051377.